TELA Bio Files 8-K
Ticker: TELA · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1561921
| Field | Detail |
|---|---|
| Company | Tela Bio, Inc. (TELA) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
TELA Bio filed a routine 8-K, no major news.
AI Summary
TELA Bio, Inc. filed an 8-K on March 31, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or material events beyond routine reporting requirements.
Why It Matters
This 8-K filing indicates TELA Bio, Inc. is fulfilling its regulatory reporting obligations with the SEC, but does not disclose new material information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and financial statements, with no indication of significant new risks or material changes.
Key Players & Entities
- TELA Bio, Inc. (company) — Registrant
- March 31, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Malvern, Pennsylvania (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for TELA Bio, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 31, 2025.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is March 31, 2025.
Where are TELA Bio, Inc.'s principal executive offices located?
TELA Bio, Inc.'s principal executive offices are located at 1 Great Valley Parkway, Suite 24, Malvern, Pennsylvania, 19355.
What is the Commission File Number for TELA Bio, Inc.?
The Commission File Number for TELA Bio, Inc. is 001-39130.
Does this filing disclose any specific new material events or financial results?
Based on the provided text, this filing is a standard 8-K reporting 'Other Events' and 'Financial Statements and Exhibits' and does not appear to disclose specific new material events or detailed financial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding TELA Bio, Inc. (TELA).